Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2004-08-26
2010-10-05
Kolker, Daniel E. (Department: 1649)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C530S350000, C435S440000
Reexamination Certificate
active
07807177
ABSTRACT:
The present invention provides a segment of glycosylation-deficient HGF having mutation(s) introduced into an amino acid sequence so as to prevent glycosylation at at least one glycosylation site of a hepatocyte growth factor (HGF), and a method of producing the same. The segment of glycosylation-deficient HGF of the present invention has the same activity as that of a segment of glycosylated HGF, therefore, it is useful as an alternate for a segment of glycosylated HGF.
REFERENCES:
patent: 2003/0162736 (2003-08-01), Nakamura et al.
Date et al. FEBS Letters 420: 1-6, Jan. 1998.
Shimizu et al. Biochemical and Biophysical Research Communications 189(3): 1329-1335, Dec. 30, 1992.
Glass and Heinz, Chapter 6, Artificial DNA Methods and Applications, Editors Khudyakov and Fields, CRC Press, London, (2003).
Mizuno et al., The Journal of Biological Chemistry, 269(2): 1131-1136, Jan. 14, 1994.
Bruce-Chwatt LJ. British Medical Journal, 285: 674-676. (1982).
Fukuta et al. Biochem J. 388:555-562 (2005).
N. Shimizu et al., “Hepatocyte Growth Factor is Linked by O-Glycosylated Oligosaccharide on the α Chain”, Biochemical and Biophysical Research Communications, vol. 189, No. 3, pp. 1329-1335, Dec. 30, 1992.
S. J. Stahl et al., “Functional and Biophysical Characterization of Recombinant Human Hepatocyte Growth Factor Isoforms Produced inEscherichia coli”, Biochem. J., vol. 326, pp. 763-772, 1997.
K. Kuba et al., “Kringle 1-4 of Hepatocyte Growth Factor Inhibits Proliferation and Migration of Human Microvascular Endothelial Cells”, Biochemical and Biophysical Research Communications, vol. 279, No. 3, pp. 846-852, Dec. 29, 2000.
R. Hofmann et al., “Scatter factor is a glycoprotein but glycosylation is not required for its activity”, Biochimica et Biophysica Acta, vol. 1120, No. 3, pp. 343-350, 1992.
N. Shimizu et al., “Hepatocyte Growth Factor is Linked by O-Glycosylated Oligosaccharide on the α Chain”, Biochemical and Biophysical Research Communications, vol. 189, No. 3, pp. 1329-1335, Dec. 30, 1992.
K. Date et al., “HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor”, FEBS Letters, vol. 420, No. 1, pp. 1-6, 1997.
K. Fukuta et al., “Multiple Biological Responses are Induced by Glycosylation-Deficient Hepatocyte Growth Factor”, Biochemical Journal, Feb. 4, 2005.
Fukuta Kazuhiro
Matsumoto Kunio
Nakamura Toshikazu
Kolker Daniel E.
Kringle Pharma Inc.
MacFarlane Stacey
Nakamura Toshikazu
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Segment of glycosylation-deficient HGFalpha-chain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Segment of glycosylation-deficient HGFalpha-chain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Segment of glycosylation-deficient HGFalpha-chain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4185731